has anyone switched from tirzepatide to semaglutide vs for Weight Loss What Happens When You Switch

The trial demonstrated that once-weekly tirzepatide 10 mg and 15 mg offered substantial and clinically meaningful bodyweight reduction, with a safety profile similar to other therapies for weight management using incretin-based approaches

Programs commonly prescribed

So maybe if enough people are on these drugs with enough effect, you could start seeing a decrease in the number of patients with the weight qualification to now meet that diagnosis if they were going to be a new patient

doi: 10.3389/fendo.2021.784716 6 Van HoeckVBolsPEJBinelliMLeroyJL

Month two is also when side effects tend to peak

Careful design and modification of NADs can mitigate immunogenicity, but this requires extensive testing